M42's Moorfields Eye Hospital Abu Dhabi restores woman's sight after 30 years of blindness - Middle East Business News and Information
Yemeni woman travels to UAE for life-changing treatment, reinforcing Abu Dhabi's status as a global healthcare hub
40-year-old describes her experience at the hospital as 'a magical journey with a fairytale ending'
Moorfields Eye Hospital Abu Dhabi redefines outcomes in complex ophthalmology cases, emphasizing the importance of a second opinion.
Abu Dhabi, United Arab Emirates, February, 2025: A Yemeni woman, left blind since childhood due to a misdiagnosis, has had her eyesight restored after receiving life-changing surgery at Moorfields Eye Hospital Abu Dhabi, part of the M42 group. The 40-year-old described her experience as 'a magical journey with a fairytale ending.'
Hanaa Mahdi Saleh Ali could only see blurred lights and struggled with basic daily activities. Her condition had a profound impact on her education, independence and quality of life. Over the years, her father consulted numerous eye specialists in different parts of the world, but, despite their efforts, she was diagnosed with permanent vision loss caused by night blindness and severe cataracts, which obscured an underlying retinal issue.
This year (2024), Hanaa's sister, who lives in the UAE, learned about how Moorfields Eye Hospital Abu Dhabi was using the latest technologies to carry out innovative work and encouraged Hanaa to seek treatment there. In October, Hanaa traveled to the UAE, where Dr. Syed M. Asad Ali, a Consultant Ophthalmologist specializing in cataract surgery at the hospital, diagnosed her with gyrate atrophy, a rare inherited condition, along with advanced cataracts and cystoid macular edema. The hospital's International Patient Services team offers a comprehensive range of eye care assessments, diagnostics and both surgical and non-surgical treatments, reinforcing Abu Dhabi's status as a global healthcare hub.
Hanaa said: 'Losing my vision when I was 10 years old was very difficult, especially as a child as I couldn't play outside with my friends or even do my day-to-day activities, such as reading or even eating normally. After hearing about the work conducted at Moorfields Eye Hospital Abu Dhabi, I realized there was still hope that my eyesight may be restored. I was apprehensive, but Dr. Syed and the team's encouragement helped me feel more positive and hopeful for a successful outcome.'
A complex case:
Gyrate atrophy is a rare genetic condition that causes a buildup of a substance called ornithine. It is diagnosed through medical history, eye examination, genetic testing and retinal imaging. The surgery to remove Hanaa's cataracts using ultrasound required careful planning, precise execution and clear communication of the risks.
A ray of hope:
In November 2024, Dr. Syed M. Asad Ali performed successful surgeries on both of Hanaa's eyes, restoring her vision after 30 years of blindness. He said: 'At Moorfields Eye Hospital Abu Dhabi, we leverage the legacy and expertise of our London counterpart to offer advanced treatments and services across the UAE. Hanaa was initially diagnosed with retinitis pigmentosa and congenital cataract, but we later identified the correct issue as gyrate atrophy with advanced cataracts and cystoid macular edema. Both conditions can present peripheral vision loss or changes in the retina.'
A new beginning:
Hanaa added: 'Since I got my vision back, I have started appreciating the little things in life more. Being able to see my family's faces is a blessing that I will never be thankful enough for. The joy of reconnecting with the world visually is indescribable. Dr. Syed, Dr. Esmaeil Mohammad Arbabi, Consultant Ophthalmologist, the nurses and the front staff were all very supportive and amazing, and I thank them every day in my prayers for all their efforts. It has been 30 years since I last saw things. Although it has been a very long time, I still remember everything clearly: my family's faces, the sky, the trees and the sea. I advise everyone who suffers from a similar medical condition, or any challenging conditions, to never give up. Belief is the key! And with all the medical advancements we now have, it is a blessing from Allah.'
Dr. Ali expressed his pride in the success of the surgery, saying: 'This case highlights the transformative potential of advanced ophthalmological care. We are thrilled with Hanaa's progress, and she is now continuing her aftercare in her home country, where we remain in contact to ensure her long-term well-being.'
At Moorfields Eye Hospital Abu Dhabi, patients like Hanaa find not just treatment but renewed opportunities to embrace life's beauty, proving that miracles can indeed happen when expertise and compassion come together.
About Moorfields Eye Hospital Centre, Abu Dhabi, United Arab Emirates:
Moorfields Eye Hospital Center, Abu Dhabi is a partnership between Moorfields Eye Hospital London and M42. M42 is a first-of-its-kind global tech-enabled health powerhouse committed to the sustainable future of health. The Abu Dhabi-headquartered company is transforming lives through innovative clinical solutions that are solving the world's most critical health and diagnostic challenges. By harnessing innovative solutions and unique medical and data-centric technologies, including genomics and AI, M42 is delivering the highest level of personalized, precise, and preventative care to impactfully disrupt the global healthcare ecosystem.
M42 has over 20,000 employees and more than 450 facilities in 26 countries. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 combines unique medical and data-centric technologies with state-of-the-art facilities to deliver world-class care.
Moorfields Eye Hospital Abu Dhabi is a renowned extension of Moorfields Eye Hospital London, the world's oldest and one of the largest centres for ophthalmic treatment, teaching, and research.
Moorfields Eye Hospital Abu Dhabi and Moorfields Eye Hospital Dubai unit in their mission to provide the highest standard of eye care, leveraging the legacy and expertise of their London counterpart to offer advanced treatments and services across the United Arab Emirates.
About M42:
M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally.
Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Mid East Info
22-03-2025
- Mid East Info
Cleveland Clinic Abu Dhabi saves vision for patient with rare invasive fungal sinusitis using advanced skull-base surgery
Timely diagnosis and advanced skull base surgery preserved the patient's vision, avoided eye removal and averted life-threatening complications. Cleveland Clinic Abu Dhabi's multidisciplinary approach and cutting-edge therapies enabled successful treatment of a rare invasive fungal sinusitis. Abu Dhabi, United Arab Emirates: Cleveland Clinic Abu Dhabi, part of the M42 group, successfully saved a 57-year-old woman's eye from a rare and invasive fungal sinusitis through an extensive skull base surgery, preventing the need for orbital exenteration (eye removal). The patient had previously undergone bilateral sinus surgery at a different hospital, which led to post-operative maxillary sinusitis – a condition where the sinuses behind the cheeks became infected or inflamed after the procedure. She was later admitted to the Emergency Department of Cleveland Clinic Abu Dhabi with severe right-sided facial pain and swelling. Despite initial treatment with antibiotics and steroids, her condition deteriorated, leading to nasal congestion, changes in her sense of smell, and debilitating headaches. Further investigation, including an MRI, revealed mucosal thickening and a breakthrough in the thin bone separating her sinuses and orbital cavity, which caused the infection to get dangerously close to her eye and potentially spread further. A swab of the affected area confirmed an invasive fungal infection caused by Aspergillus; an infection caused by a type of fungus. If left untreated, the infection would have invaded deeper tissues of the orbit and possibly spread to nearby structures such as the brain, posing a significant threat to her life. A multidisciplinary team led by Dr. Mahdi Shkoukani, Department Chair for Otolaryngology Head & Neck Surgery in the Surgical Subspecialties Institute at Cleveland Clinic Abu Dhabi, quickly recognized the urgency of the patient's condition. They performed an extensive surgical debridement to remove the infected tissue, including parts of the sinuses, the medial orbital wall, and the orbital fat around the eye. Explaining the complex nature of the condition, Dr. Mahdi Shkoukani said: 'This was one of the rarest cases of sinusitis we encountered in recent years. Despite the patient being healthy and having a functioning immune system, the patient's fungal infection had progressed to a point where it posed a serious threat to her eye and brain if left untreated. The case underscores the importance of early diagnosis and rapid surgical and medical intervention for invasive fungal sinusitis. Through a complex and meticulous surgical procedure, we successfully removed all the infected tissue while preserving her vision. The multidisciplinary teamwork at Cleveland Clinic Abu Dhabi played a crucial role in achieving this positive outcome. We hope this story raises awareness about the severity of such infections and the importance of seeking immediate medical attention when symptoms persist or worsen.' Following surgery, the patient's infection subsided, and her tissues began to heal. A second procedure two days later confirmed no further fungal invasion, sparing her from orbital exenteration. She was started on antifungal medications from day one when we first suspected the infection and was closely managed by the infectious disease team. Today, her sinuses have healed and her vision remains intact. Dr. Shkoukani commented further: 'Fungi are typically harmless and naturally present in the sinuses. However, in certain conditions, they can become aggressive, spreading to surrounding tissues, including the eyes and brain. In patients with compromised immune systems, this invasion can progress rapidly, leading to a condition known as acute invasive fungal sinusitis. In immune-competent individuals, like our patient, the progression is usually slower, resulting in chronic invasive sinusitis. At Cleveland Clinic Abu Dhabi, our advanced facilities and multidisciplinary expertise enable us to manage such complex cases with precision and care.' Reflecting on her journey, the patient shared: 'I'm incredibly grateful to the team at Cleveland Clinic Abu Dhabi for their swift action and expertise. It was a terrifying experience to think I might lose my eye, but their dedication and skill saved me. I never imagined something like a sinus infection could become so dangerous, and I hope my story encourages others to seek help early if they have persistent symptoms.' This case, out of many, underscores Cleveland Clinic Abu Dhabi's expertise in complex care and its commitment to innovation and patient-centered care. The hospital continues to make a transformative impact in the lives of patients with world-class care. The hospital's Integrated Surgical Institute combines cutting-edge diagnostics and surgical expertise to address complex cases like this. Raising public awareness about symptoms such as persistent facial pain and swelling, coupled with early medical intervention, can prevent severe complications. About Cleveland Clinic Abu Dhabi: Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital located on Al Maryah Island in Abu Dhabi, UAE. As an extension of Cleveland Clinic in the U.S., it is uniquely designed to address the complex and critical care needs of the UAE and the broader region. The hospital is organized into specialized Institutes, including Heart, Vascular & Thoracic; Neurological; Cancer; Digestive Disease; Medical Subspecialties; Integrated Surgical Subspecialties; Integrated Hospital Care; and Diagnostic. Celebrating its 10th anniversary in 2025, Cleveland Clinic Abu Dhabi is a 405-bed hospital, including 321 acute care beds, 84 critical care beds, four royal suites, and 26 operating rooms. Its state-of-the-art facilities provide patients in the region with direct access to world-class healthcare providers and Cleveland Clinic's renowned model of care. The hospital is also home to the Fatima bint Mubarak Center, a dedicated cancer center offering comprehensive diagnostics and advanced treatment across 24 clinical departments, covering a range of cancer subspecialties and programs. Committed to medical innovation, Cleveland Clinic Abu Dhabi integrates robotics across specialties, pioneers' endovascular therapy and hybrid procedures, and offers comprehensive programs in heart failure, heart transplantation, and limb salvage. Licensed by the Department of Health – Abu Dhabi as a designated research and teaching facility, Cleveland Clinic Abu Dhabi drives medical innovation through clinical trials and advanced research to enhance patient care. It is the first hospital in the UAE accredited by both the Accreditation Council for Graduate Medical Education International (ACGMEI) and the Accreditation Council for Continuing Medical Education (ACCME), offering residency and fellowship programs, undergraduate health professional training, and Continuing Medical Education (CME). M42 is a global, tech-enabled healthcare company based in Abu Dhabi, operating at the forefront of medical advancement.
Mid East Info
27-02-2025
- Mid East Info
Cleveland Clinic Abu Dhabi reports 35% growth in international patient volume for 2024, boosting the UAE's position in medical tourism
TRIYAS_2023_ABUDAHABI Cleveland Clinic Abu Dhabi recorded over 10,000 international patients encounters in 2024, underscoring its position as a trusted destination for world class care The hospital's continuous investment in cutting-edge technology, medical innovation, and pioneering research has earned it multiple regional and international accreditations Abu Dhabi, United Arab Emirates. February, 2025: Cleveland Clinic Abu Dhabi, part of the M42 group, has recorded a 35% increase in international patient volume in 2024, cementing its position as a global destination for world-class care. Over the past twelve months, the hospital saw more than 10,000 international patients encounters, demonstrating its leadership in advanced and specialized care powered by cutting-edge technology and multidisciplinary expertise. Renowned for its excellence in complex care, Cleveland Clinic Abu Dhabi saw increased interest in its advanced services, mainly in the aeras of cardiology, ophthalmology, neurology and urology, with Kuwait, Saudi Arabia, Pakistan, Bahrain and USA being the top five countries where international patients are flying from to Abu Dhabi in 2024. As part of the Cleveland Clinic global network, the hospital ensures a seamless experience for its international patients through its representation in key regions worldwide. Its ongoing investment in advanced technology, medical innovation and research has earned it prestigious regional and international accreditations and certifications, underscoring its reputation as a premier healthcare destination. This growth highlights the hospital's leadership in medical innovation and reinforces the UAE's position as a premier hub for medical tourism. Dr. Georges – Pascal Haber, CEO of Cleveland Clinic Abu Dhabi, stated: 'At Cleveland Clinic Abu Dhabi, we are redefining healthcare in the UAE and beyond. Our vision is to become the premier destination for patients worldwide, delivering world-class, multidisciplinary care tailored to each individual's needs—all within a single, state-of-the-art facility. What truly distinguishes us is not only our medical expertise but also our unwavering commitment to enhancing patient outcomes. We are gaining global recognition and attracting patients who view the UAE as a hub for groundbreaking medical advancements. Our approach is setting a new standard for the future of healthcare—rooted in excellence, teamwork, and compassion. We are pushing the boundaries of possibility, ensuring that every patient, regardless of where they come from, departs with the confidence that they have received the best care available.' Worth noting that in 2023, Cleveland Clinic Abu Dhabi recorded over 7,400 encounters for international patients, primarily from Kuwait, Saudi Arabia, Pakistan, Oman and Bahrain. Today, with its reputation for delivering high-quality medical services and complex care through its state-of-the-art institutes, including the Multi-Organ Transplant Center and the Fatima Bint Mubarak Oncology Center, Cleveland Clinic Abu Dhabi is attracting patients from around the globe. Recalling her visit to the UAE, Esther Ritzmann, a Swiss national who survived a rare and life-threatening stroke, said: 'I never expected that my vacation in the UAE would turn into a life-saving journey. I remember feeling my body completely paralyze. I felt trapped in my own body, unable to move, and the seizures hit me like waves. Somewhere in my subconscious, I thought I was going to die.' Reflecting on her experience at Cleveland Clinic Abu Dhabi, Esther continued: 'But when I arrived at Cleveland Clinic Abu Dhabi, everything changed. The team's swift action, their expertise, and the way they communicated with me, even when I could barely respond, made me feel safe. I immediately trusted them with my life. Despite being thousands of miles away from home, I knew I was exactly where I needed to be. Their exceptional care saved my life, and I'll forever be grateful for how they gave me the chance to recover and live again.' Cleveland Clinic Abu Dhabi's International Patient Services is designed to offer patients a seamless experience and provide access to world-class healthcare across a wide range of specialties. The program delivers personalized support throughout the entire patient journey, with a dedicated coordinator serving as a single point of contact. Services include scheduling appointments, travel assistance, managing medical records, cost estimation and payment support, hospital admission support and facilitating critical care transfers. The hospital plans to broaden its array of medical services by introducing specialized offerings that cater to the evolving needs of patients from around the world. About Cleveland Clinic Abu Dhabi: Cleveland Clinic Abu Dhabi, part of the M42 group, is a multispecialty hospital on Al Maryah Island in Abu Dhabi, UAE. Cleveland Clinic Abu Dhabi is a unique and unparalleled extension of US-based Cleveland Clinic's model of care, specifically designed to address a range of complex and critical care requirements unique to the Abu Dhabi population. Cleveland Clinic Abu Dhabi has the following Institutes and Departments: Heart, Vascular & Thoracic, Neurology, Digestive Disease, Eye, Respiratory, Critical Care, Oncology, Transplant, Surgical Subspecialties, Medical Subspecialties, Emergency Medicine, Anesthesiology, Pathology & Laboratory Medicine, Imaging, Quality & Patient Safety, Clinical & Nursing, Research and Education Departments. In all, more than 50 medical and surgical specialties are offered at Cleveland Clinic Abu Dhabi. The campus is also home to a stand-alone and dedicated cancer center, Fatima bint Mubarak Center. The state-of-the-art, facility provides patients with access to diagnostics and treatment options through world- class facilities across 24 clinical departments that include a range of cancer subspecialties and programs: Blood Cancers, Breast Cancers, Endocrine Cancers, Gastrointestinal Cancers, Genitourinary Cancers, Gynecological Cancers, Head and Neck Cancers, Neurological Cancers, Thoracic Cancers, Ophthalmological Cancers and Soft Tissue Cancers among others. Cleveland Clinic Abu Dhabi provides patients in the region with direct access to the world's best healthcare providers and Cleveland Clinic's unique model of care that includes state-of-the-art amenities and world- class service standards closer to home. M42 is an Abu Dhabi-based, global tech-enabled healthcare company operating at the forefront of medical advancement.
Mid East Info
10-02-2025
- Mid East Info
Endurance champion triumphs in grueling 7 Emirates Challenge with support from M42's Healthpoint and Mubadala Health Dubai
In an extraordinary feat of endurance, British expat and Dubai-based consultant Harry Amos has successfully completed the 7 Emirates Challenge in record-breaking time, 5 days, 21 hours, and 30 minutes. Supported by M42, a global health champion powered by artificial intelligence (AI) and technology, Healthpoint and Mubadala Health Dubai, Harry was backed by a dedicated team of expert physiotherapists who provided crucial rehabilitation and recovery support throughout his journey. Harry embarked on the 7 Emirates Challenge on February 1, determined to complete the grueling 630 kilometers run across the UAE, from Fujairah to the UAE-Saudi Arabia border, in under six days. More than a test of endurance, the challenge aimed to raise awareness about diabetes, making his achievement even more impactful. Despite battling exhaustion, he pushed his limits with the support of the M42 group, ultimately finishing the challenge successfully. After completing the run, he visited Healthpoint for a recovery session and a celebratory ceremony. 'This journey has been one of the toughest challenges of my life but knowing that I was running for a cause bigger than myself kept me going,' said Harry, 'I'm incredibly grateful to M42, Healthpoint and Mubadala Health Dubai for their unwavering support in ensuring I stayed strong and injury-free throughout this challenge. I hope that I have inspired others to be mindful of their physical health and to keep moving.' With an estimated 1.6 million UAE residents at risk of type 2 diabetes by 2031, Harry and M42's group mission was more than endurance, it was a call for awareness and prevention. Dr. Hasan Baydoun, Consultant Orthopedic Surgeon and Head of the Orthopedic Department at Healthpoint and Mubadala Health Dubai, said, 'We are thrilled to have played a role in Harry's extraordinary success. Our expert team of physiotherapists and sports medicine experts was on hand to assist him throughout every stage of his journey, ensuring he remained strong and injury-free. At M42, we are committed to spreading awareness around health and well-being, while delivering world-class care to our patients and the community.' About Healthpoint: Healthpoint, part of the M42 group, is a multi-specialty hospital based in Abu Dhabi. The hospital includes a wide range of primary and specialty care services, and five centers of excellence: Obesity Management, Metabolic and Bariatric Surgery Center of Excellence, Dentistry, Endoscopy, Orthopedics & Sports Medicine, Physiotherapy & Rehabilitation. Focusing on a carefully defined set of medically integrated services and practices, Healthpoint's patient-centered approach is organized around medical conditions over the full cycle of care and delivered in integrated practice units (IPUs). Committed to elevating patient care to the highest standards, Healthpoint has been recognized by numerous renowned international awarding and accrediting bodies. These include the Commission on Accreditation of Rehabilitation Facilities (CARF International), the Joint Commission International (JCI), the Australian Council on Healthcare Standards International (ACHSI), and the American Surgical Review Corporation (SRC). About Mubadala Health Dubai: Mubadala Health Dubai is a specialty clinic and day surgery center. Established in 2022, it is the first of M42's strategic expansions outside of Abu Dhabi. It provides comprehensive diagnostic services with international standards for adults and children and a continuum of care for communities in Dubai. Located in Sunset Mall, Jumeirah 3, Mubadala Health Dubai brings a multidisciplinary model of care delivered through a western-board certified medical team from over 30 clinical specialties across M42's network of world-class healthcare assets, including Imperial College London Diabetes Centre and Cleveland Clinic Abu Dhabi. The 125,000-square foot state-of-the-art facility includes medical and pediatric specialty clinics, a day surgery center, 96 consultation rooms, four operating rooms, two endoscopy suites, as well as an in-house laboratory, in-house pharmacy, a radiology department, dedicated rehabilitation gyms, and dedicated procedure rooms. It also offers a one-of-a-kind post-operative lounge where patients receive comprehensive education from the multidisciplinary team after surgery to optimize their discharge. Mubadala Health Dubai is on Twitter, Instagram, Facebook and LinkedIn with the handle: @mubadalahealthdubai About M42: M42 is a global health champion powered by artificial intelligence (AI), technology and genomics to advance innovation in health for people and the planet. Headquartered in Abu Dhabi, M42 combines its specialized, state-of-the-art facilities with integrated health solutions like genomics and biobanks, and harnesses advanced technologies to deliver precise, preventive and predictive care, to impactfully disrupt traditional healthcare models and positively impact lives globally. Established in 2022, following the coming together of G42 Healthcare and Mubadala Health, M42 has more than 480 facilities in 26 countries and over 20,000 employees. M42 includes renowned healthcare providers including Cleveland Clinic Abu Dhabi, Danat Al Emarat, Diaverum, Imperial College London Diabetes Centre, Sheikh Sultan bin Zayed Hospital, and Moorfields Eye Hospital Abu Dhabi. As well as operating the Emirati Genome Programme, M42 runs Abu Dhabi BioBank and Abu Dhabi Health Data Services (ADHDS), a global tech-enabled healthcare company operating Malaffi.
